| Literature DB >> 24612671 |
Meinie Seelen1, Anne E Visser1, Daniel J Overste1, Hong J Kim2, A Palud2, Tsz H Wong3, John C van Swieten4, Philip Scheltens5, Nicol C Voermans6, Frank Baas7, J M B V de Jong8, Anneke J van der Kooi8, Marianne de Visser8, Jan H Veldink1, J Paul Taylor2, Michael A Van Es9, Leonard H van den Berg1.
Abstract
Inclusion body myopathy (IBM) associated with Paget disease of the bone, frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (ALS), sometimes called IBMPFD/ALS or multi system proteinopathy, is a rare, autosomal dominant disorder characterized by progressive degeneration of muscle, brain, motor neurons, and bone with prominent TDP-43 pathology. Recently, 2 novel genes for multi system proteinopathy were discovered; heterogenous nuclear ribonucleoprotein (hnRNP) A1 and A2B1. Subsequently, a mutation in hnRNPA1 was also identified in a pedigree with autosomal dominant familial ALS. The genetic evidence for ALS and other neurodegenerative diseases is still insufficient. We therefore sequenced the prion-like domain of these genes in 135 familial ALS, 1084 sporadic ALS, 68 familial FTD, 74 sporadic FTD, and 31 sporadic IBM patients in a Dutch population. We did not identify any mutations in these genes in our cohorts. Mutations in hnRNPA1 and hnRNPA2B1 prove to be a rare cause of ALS, FTD, and IBM in the Netherlands.Entities:
Keywords: Amyotrophic lateral sclerosis (ALS); Frontotemporal dementia (FTD); Inclusion body myopathy (IBM); hnRNPA1; hnRNPA2B1
Mesh:
Substances:
Year: 2014 PMID: 24612671 DOI: 10.1016/j.neurobiolaging.2014.01.152
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673